SCHEMBL6600783

SCHEMBL6600783

CCOc1cc(C2=NN(C(=O)c3ccccc3NC(=O)c3ccncc3)CCC2)ccc1OC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.43
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
AAK1 Q2M2I8 1/20 0.42
ALDH1A1 P00352 3/20 0.42
MAOB P27338 1/20 0.41
NPC1 O15118 2/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDE4B Q07343 1/20 0.40
CFTR P13569 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6601582 0.94 MAOB (0.48) RXFP1TP53MAPTAAK1ALDH1A1
SCHEMBL6602823 0.92 AAK1 (0.48) TP53MAPTAAK1ALDH1A1PKM
SCHEMBL7646891 0.88 MAOB (0.41) RXFP1MAPTAAK1ALDH1A1MAOB
SCHEMBL6603362 0.88 PDE5A (0.54) MEN1KMT2APDE4B
SCHEMBL6601230 0.86 HTT (0.47) MAPTALDH1A1MAOBPKMLMNA
SCHEMBL6600753 0.86 SMN1; SMN2 (0.44) ALDH1A1MAOBNPC1PKMRAB9A
SCHEMBL6602257 0.86 ALDH1A1 (0.43) MAPTALDH1A1MAOBNPC1PKM
Hydrochloric Acid SCHEMBL7646217 0.85 HTT (0.47) MAPTALDH1A1MAOBPKMLMNA
SCHEMBL143512 0.85 AAK1 (0.52) TP53MAPTAAK1ALDH1A1MAOB
SCHEMBL6605566 0.85 CFTR (0.47) RXFP1TP53MAPTALDH1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
EP-1143944-A3 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GmbH (DE) 2002-09-11 EP disclosed
EP-1143944-A2 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GmbH (DE) 2001-10-17 EP disclosed
WO-2000059484-A2 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GMBH (DE) 2000-10-12 WO disclosed